Early Screening Critical to Address Comorbidities in Older Patients With HIV
As the earliest patients to be diagnosed with HIV age, early screening has become critical to address the impact of comorbidities in older patients with HIV.
Read MoreJul 16, 2024
As the earliest patients to be diagnosed with HIV age, early screening has become critical to address the impact of comorbidities in older patients with HIV.
Read MoreJul 15, 2024
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read MoreJul 15, 2024
In a recent study of supportive care for advanced cancer management, targeted palliative care optimized patient care and enhanced clinical outcomes.
Read MoreJul 15, 2024
Immerse yourself in retinal science advancements, therapeutics, innovation and fellowship at the 42nd ASRS Annual Scientific Meeting July 17-20, 2024.
Read MoreJul 14, 2024
Severe depression and anxiety increased mortality risk in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation.
Read MoreJul 14, 2024
Structural and functional differences in the Achilles tendon could be clinically relevant when managing pain in patients with psoriatic arthritis.
Read MoreJul 13, 2024
Zanubrutinib plus venetoclax delivered promising preliminary efficacy results in newly diagnosed CLL/SLL in participants with del(17p) and/or TP53 mutations.
Read MoreJul 13, 2024
Patients with pre-treated relapsed or refractory follicular lymphoma have shown benefits with mosunetuzumab.
Read MoreJul 13, 2024
Anitocabtagene autoleucel therapy showed promising results in patients with relapsed or refractory multiple myeloma.
Read MoreJul 12, 2024
PrEP use among gay, bisexual, and queer men is dynamic, with no singular approach favored, and results warrant educational efforts on adaptable PrEP strategies.
Read MoreJul 11, 2024
The AUGMENT-101 trial in patients with in KMT2Ar leukemia has been stopped early because of revumenib encouraging anti-tumor activity.
Read MoreJul 11, 2024
Pelabresib plus ruxolitinib has shown efficacy in the treatment responses of patients with myelofibrosis.
Read MoreJul 11, 2024
Sovleplenib may offer QOL improvements for patients with primary immune thrombocytopenia.
Read MoreJul 11, 2024
Oral agents have show good efficacy results in patients with psoriasis. An oral agent is also easier for patients to intake then other forms of medication.
Read MoreJul 11, 2024
The association between obesity and psoriatic disease. Smoking, genetics, as well as obesity, all potentially contribute to the development of psoriasis in all age groups.
Read MoreJul 11, 2024
In a new study, researchers explore the relationship between psoriasis and depression, and how depression can be addressed with different forms of therapy.
Read MoreJul 11, 2024
Adding additional clinical and genetic information improved the performance of prognostic scores in secondary myelofibrosis, researchers in France report.
Read MoreJul 11, 2024
With new research, medical professionals are even closer to implementing personalized medicine in care for patients with psoriatic arthritis.
Read MoreJul 11, 2024
Immunological and genetic studies are changing the way medical professionals understand psoriatic disease, the risks, and how patients could respond to treatment.
Read MoreJul 10, 2024
Multimodal analysis of synovial tissue may identify patients with rheumatoid arthritis who subsequently respond to treatment with DMARDs.
Read More